Login / Signup

Correction: Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial.

Sylvie ChevretLila BouadmaClaire DupuisCharles BurdetJean François Timsitnull null
Published in: Annals of intensive care (2023)
Keyphrases
  • high dose
  • low dose
  • stem cell transplantation
  • sars cov
  • early onset
  • double blind
  • drug induced